- Home
- AMSC vs RCUS Comparison
AMSC vs RCUS Comparison
Compare AMSC & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMSC
- RCUS
- Stock Information
- Founded
- AMSC 1987
- RCUS 2015
- Country
- AMSC United States
- RCUS United States
- Employees
- AMSC N/A
- RCUS N/A
- Industry
- AMSC Metal Fabrications
- RCUS Biotechnology: Pharmaceutical Preparations
- Sector
- AMSC Consumer Discretionary
- RCUS Health Care
- Exchange
- AMSC Nasdaq
- RCUS Nasdaq
- Market Cap
- AMSC 1.3B
- RCUS 1.4B
- IPO Year
- AMSC 1991
- RCUS 2018
- Fundamental
- Price
- AMSC $34.22
- RCUS $14.71
- Analyst Decision
- AMSC Strong Buy
- RCUS Buy
- Analyst Count
- AMSC 3
- RCUS 12
- Target Price
- AMSC $28.33
- RCUS $34.50
- AVG Volume (30 Days)
- AMSC 1.7M
- RCUS 741.6K
- Earning Date
- AMSC 01-22-2025
- RCUS 11-06-2024
- Dividend Yield
- AMSC N/A
- RCUS N/A
- EPS Growth
- AMSC N/A
- RCUS N/A
- EPS
- AMSC N/A
- RCUS N/A
- Revenue
- AMSC $176,142,000.00
- RCUS $263,000,000.00
- Revenue This Year
- AMSC $47.52
- RCUS $112.97
- Revenue Next Year
- AMSC $18.53
- RCUS N/A
- P/E Ratio
- AMSC N/A
- RCUS N/A
- Revenue Growth
- AMSC 46.93
- RCUS 119.17
- 52 Week Low
- AMSC $8.56
- RCUS $13.50
- 52 Week High
- AMSC $38.02
- RCUS $20.31
- Technical
- Relative Strength Index (RSI)
- AMSC 62.68
- RCUS 40.35
- Support Level
- AMSC $29.55
- RCUS $14.15
- Resistance Level
- AMSC $35.09
- RCUS $15.01
- Average True Range (ATR)
- AMSC 3.24
- RCUS 1.00
- MACD
- AMSC 0.00
- RCUS -0.20
- Stochastic Oscillator
- AMSC 65.17
- RCUS 11.49
About AMSC American Superconductor Corporation
American Superconductor Corp generates the ideas, technologies, and solutions that meet world's demand for smarter, cleaner and energy. Through its Windtec Solutions, the company enables manufacturers to launch wind turbines quickly, effectively and profitably. Through its Gridtec Solutions, the company provides engineering planning services and grid systems that optimize network reliability, efficiency and performance. The company's segment includes Grid and Wind. It generates maximum revenue from the Grid segment.
About RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.